SSA
CINC

Schonfeld Strategic Advisors’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-250,556
Closed -$3.08M – 2954
2022
Q4 		$3.08M Buy
+250,556
New +$5.97M 0.03% 657

Schonfeld Strategic Advisors's CINC Position: Q1 2023 in Review

Schonfeld Strategic Advisors sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 250,556 shares — an estimated $3.08M sold.

Schonfeld Strategic Advisors first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $3.08M in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Schonfeld Strategic Advisors reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 250,556 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $3.08M.
  • Schonfeld Strategic Advisors first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's CinCor Pharma, Inc. Common Stock position peaked at $3.08M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.